Glaxo will lead in Egypt after purchase
LONDON (Reuters) - GlaxoSmithKline is buying the Egyptian mature products business of Bristol-Myers Squibb for $210 million (120 million pounds), to extend the drug company's recent expansion into emerging markets....
10/15/2008 10:27:52 AM
Reuters: Business News
|
